Additionally, the HPV status influenced the treatment response to tyrosine kinase inhibitors with regard to AREG expression, underlining the necessity to consider HPV infection for therapy of HNSCC [52]. The gene discussed is AREG; the disease is head and neck squamous cell carcinoma.